BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38220203)

  • 1. [Neutralization of hepatitis B virus with vaccine-escape mutations by novel hepatitis B vaccine with large-HBs antigen].
    Kato T; Akari H
    Uirusu; 2023; 72(2):149-158. PubMed ID: 38220203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen.
    Washizaki A; Murayama A; Murata M; Kiyohara T; Yato K; Yamada N; Aly HH; Tanaka T; Moriishi K; Nishitsuji H; Shimotohno K; Goh Y; Ishii KJ; Yotsuyanagi H; Muramatsu M; Ishii K; Takahashi Y; Suzuki R; Akari H; Kato T
    Nat Commun; 2022 Sep; 13(1):5207. PubMed ID: 36064848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.
    Kato M; Hamada-Tsutsumi S; Okuse C; Sakai A; Matsumoto N; Sato M; Sato T; Arito M; Omoteyama K; Suematsu N; Okamoto K; Kato T; Itoh F; Sumazaki R; Tanaka Y; Yotsuyanagi H; Kato T; Kurokawa MS
    J Gastroenterol; 2017 Sep; 52(9):1051-1063. PubMed ID: 28197802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
    Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
    Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
    Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
    Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
    Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B vaccines-history, achievements, challenges, and perspectives].
    Gerlich WH
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Feb; 65(2):170-182. PubMed ID: 35015108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity pattern of monoclonal antibodies against Hepatitis B vaccine with global Hepatitis B virus genotypes.
    Golsaz-Shirazi F; Asadi-Asadabad S; Sarvnaz H; Mehdi Amiri M; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Shokri F
    Clin Chim Acta; 2020 Nov; 510():203-210. PubMed ID: 32679130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.
    Qin Y; Liao P
    Acta Virol; 2018; 62(2):115-121. PubMed ID: 29895151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection.
    Fu X; Chen J; Chen H; Lin J; Xun Z; Li S; Liu C; Zeng Y; Chen T; Yang B; Ou Q
    J Med Virol; 2017 Aug; 89(8):1419-1426. PubMed ID: 28198078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge.
    del Valle JR; Devaux P; Hodge G; Wegner NJ; McChesney MB; Cattaneo R
    J Virol; 2007 Oct; 81(19):10597-605. PubMed ID: 17634218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B vaccination.
    Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
    Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays.
    Kfoury Baz EM; Zheng J; Mazuruk K; Van Le A; Peterson DL
    Transfus Med; 2001 Oct; 11(5):355-62. PubMed ID: 11696228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new vaccine escape mutant of hepatitis B virus causes occult infection.
    Ye Q; Shang SQ; Li W
    Hum Vaccin Immunother; 2015; 11(2):407-10. PubMed ID: 25692622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice.
    Zhang TY; Guo XR; Wu YT; Kang XZ; Zheng QB; Qi RY; Chen BB; Lan Y; Wei M; Wang SJ; Xiong HL; Cao JL; Zhang BH; Qiao XY; Huang XF; Wang YB; Fang MJ; Zhang YL; Cheng T; Chen YX; Zhao QJ; Li SW; Ge SX; Chen PJ; Zhang J; Yuan Q; Xia NS
    Gut; 2020 Feb; 69(2):343-354. PubMed ID: 30926653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers.
    Zou H; Chen Y; Duan Z; Zhang H
    PLoS One; 2011; 6(10):e26748. PubMed ID: 22053208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.